Considering that approximately 10% of all diabetes cases in the Netherlands are type 1 diabetes, which is treated with insulin by definition, we then estimate that, within the population of individuals with insulin-dependent diabetes, and thus the potential users in our study, approximately 36–53% have type 1 diabetes. The gene discussed is INS; the disease is type 1 diabetes mellitus.